Antimicrobial resistance and life insurance - Summary and references

The world is facing into a huge a threat. After decades of mortality and morbidity improvements antimicrobial resistance (AMR) is predicted to wipe out recent medical gains, with diseases such as tuberculosis, rheumatic fever and gonorrhoea already making a come back .

Quantifying the Economic and Clinical Value of Reducing

STP rates: a KPI?, Gail Jones posted on the topic

Microorganisms, Free Full-Text

Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan

The global toll of antimicrobial resistance: 1.27 million deaths

The Garbage-Healthcare-Nudge

Does your decision making take the biscuit?

Fighting Antimicrobial Resistance

Optimising antimicrobial use in humans – review of current

Gail Jones on LinkedIn: As someone back out in the job market (and

Gail Jones on LinkedIn: Indonesia to offer tax-free visas for

Quantifying the Economic and Clinical Value of Reducing

Antimicrobial Resistance Network (AMRNet): One Health approach to